State of Fribourg completes acquisition of former animal health research sites

As announced by the State of Fribourg in January 2017, it entered into agreements for the acquisition of all Swiss properties of the former animal health research sites of Elanco Centre de Recherche Santé Animale SA (a subsidiary of Eli Lilly & Company). The transaction was successfully completed in June 2017. The acquired Swiss properties consist of more than 1.4 million square meters of land located in the communes of Saint Aubin and Avenches as well as in the commune of Marly.

Lenz & Staehelin advised the seller Eli Lilly & Company as Swiss counsel in this transaction.

The team was led by partner Beat Kühni and included Fabiano Menghini and Livia Koller (all Real Estate, Corporate and M&A).